Minerva Neurosciences (NERV) Depreciation & Amortization (CF) (2014 - 2025)
Minerva Neurosciences posted quarterly Depreciation & Amortization (CF) of $1360.0 for Q4 2025, little changed year-on-year from $1360.0 in Q4 2024, and little changed on a QoQ basis from $1361.0 in Q3 2025.
Minerva Neurosciences (NERV) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $1360.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1360.0; the trailing twelve-month figure through Mar 2026 stood at $4081.0 (down 25.02% YoY), and the FY2025 full-year result was $5442.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 stood at $1360.0, roughly flat from $1361.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1361.0 in Q2 2023 and bottomed at $1360.0 in Q1 2023.
- The 3-year median for Depreciation & Amortization (CF) is $1360.5 (2023), against an average of $1360.5.
- Peak annual rise in Depreciation & Amortization (CF) reached 0.07% in 2024, while the deepest fall reached 0.07% in 2024.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $1361.0 in 2023, then slipped by 0.07% to $1360.0 in 2024, then changed by 0.0% to $1360.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $1360.0 (Q4 2025), $1361.0 (Q3 2025), and $1360.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,360.00 |
| Dec 31, 2025 | 1,360.00 |
| Sep 30, 2025 | 1,361.00 |
| Sep 30, 2025 | 1,361.00 |
| Jun 30, 2025 | 1,360.00 |
| Jun 30, 2025 | 1,360.00 |
| Mar 31, 2025 | 1,361.00 |
| Mar 31, 2025 | 1,361.00 |
| Dec 31, 2024 | 1,360.00 |
| Dec 31, 2024 | 1,360.00 |
| Sep 30, 2024 | 1,361.00 |
| Sep 30, 2024 | 1,361.00 |
| Jun 30, 2024 | 1,361.00 |
| Jun 30, 2024 | 1,361.00 |
| Mar 31, 2024 | 1,360.00 |
| Mar 31, 2024 | 1,360.00 |
| Dec 31, 2023 | 1,361.00 |
| Dec 31, 2023 | 1,361.00 |
| Sep 30, 2023 | 1,360.00 |
| Sep 30, 2023 | 1,360.00 |
| Jun 30, 2023 | 1,361.00 |
| Jun 30, 2023 | 1,361.00 |
| Mar 31, 2023 | 1,360.00 |
| Mar 31, 2023 | 1,360.00 |
| Dec 31, 2020 | 2,911.00 |
| Dec 31, 2020 | 2,911.00 |
| Sep 30, 2020 | 4,367.00 |
| Sep 30, 2020 | 4,367.00 |
| Jun 30, 2020 | 4,366.00 |
| Jun 30, 2020 | 4,366.00 |
| Mar 31, 2020 | 4,367.00 |
| Mar 31, 2020 | 4,367.00 |
| Dec 31, 2019 | 4,367.00 |
| Dec 31, 2019 | 4,367.00 |
| Sep 30, 2019 | 4,366.00 |
| Sep 30, 2019 | 4,366.00 |
| Jun 30, 2019 | 4,367.00 |
| Jun 30, 2019 | 4,367.00 |
| Mar 31, 2019 | 4,367.00 |
| Mar 31, 2019 | 4,367.00 |
| Dec 31, 2018 | 4,367.00 |
| Dec 31, 2018 | 4,367.00 |
| Sep 30, 2018 | 4,366.00 |
| Sep 30, 2018 | 4,366.00 |
| Jun 30, 2018 | 4,367.00 |
| Jun 30, 2018 | 4,367.00 |
| Mar 31, 2018 | 4,367.00 |
| Mar 31, 2018 | 4,367.00 |
| Dec 31, 2017 | 1,784.00 |
| Dec 31, 2017 | 1,784.00 |
| Sep 30, 2017 | 2,706.00 |
| Sep 30, 2017 | 2,706.00 |
| Jun 30, 2017 | 3,302.00 |
| Jun 30, 2017 | 3,302.00 |
| Mar 31, 2017 | 3,302.00 |
| Mar 31, 2017 | 3,302.00 |
| Dec 31, 2016 | 3,571.00 |
| Dec 31, 2016 | 3,571.00 |
| Sep 30, 2016 | 4,320.00 |
| Sep 30, 2016 | 4,320.00 |
| Jun 30, 2016 | 4,319.00 |
| Jun 30, 2016 | 4,319.00 |
| Mar 31, 2016 | 4,320.00 |
| Mar 31, 2016 | 4,320.00 |
| Dec 31, 2015 | 4,319.00 |
| Dec 31, 2015 | 4,319.00 |
| Sep 30, 2015 | 4,320.00 |
| Sep 30, 2015 | 4,320.00 |
| Jun 30, 2015 | -1,074.00 |
| Jun 30, 2015 | -1,074.00 |
| Mar 31, 2015 | 9,711.00 |
| Mar 31, 2015 | 9,711.00 |
| Dec 31, 2014 | 3,990.00 |
| Dec 31, 2014 | 3,990.00 |
| Sep 30, 2014 | 25,608.00 |
| Sep 30, 2014 | 25,608.00 |
| Jun 30, 2014 | 4,001.00 |
| Jun 30, 2014 | 4,001.00 |
| Mar 31, 2014 | 270.00 |
| Mar 31, 2014 | 270.00 |